Occult hepatitis B virus infection in HIV-infected patients with isolated hepatitis B core antibody

Intervirology

Volumn 51, Issue 4, 2008, Pages 270-274

  Azadmanesh, Kayhan ^a   Mohraz, Minoo ^b   Aghakhani, Arezoo ^a   Edalat, Rozita ^a   Jam, Sara ^b   Eslamifar, Ali ^a   Banifazl, Mohammad ^c   Moradmand Badie, Banafsheh ^b   Ramezani, Amitis ^a  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Iranian Society for Support of Patients with Infectious Diseases   (Iran)

Author keywords

Hepatitis B core antibody, isolated; Hepatitis B virus infection, occult; Human immunodeficiency virus

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HEPATITIS B CORE ANTIBODY; VIRUS DNA;

ADULT; ARTICLE; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IRAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; VIRUS DETECTION;

ADULT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; CD4 LYMPHOCYTE COUNT; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C ANTIBODIES; HIV INFECTIONS; HUMANS; IRAN; MALE; MIDDLE AGED; VIRAL LOAD;

HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 54749134309     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000160217     Document Type: Article

References (29)

1. Lee WM: Hepatitis B virus infection. N Engl J Med 1997;337:1733-1745.
2. Grob P, Jilg W, Bornhak H, Gerken G, Gerlich W, Gunther S, Hess G, Hudig H, Kitchen A, Margolis H, Michel G, Trepo C, Will H, Zanetti A, Mushahwar I: Serological pattern 'anti-HBc alone': report on a workshop. J Med Virol 2000;62:450-455.
3. Weber B, Melchior W, Gehrke R, Doerr HW, Berger A, Rabenau H: Hepatitis B virus markers in anti-HBc only positive individuals. J Med Virol 2001;64:312-319.
4. Neau D, Winnock M, Jouvencel AC, Faure M, Castera L, Legrand E, Lacoste D, Ragnaud JM, Dupon M, Fleury H, Lafon ME, Dabis F; Groupe d'Epidé miologie Clinique du SIDA en Aquitaine: Occult hepatitis B virus infection in HIV-infected patients with isolated antibodies to hepatitis B core antigen: Aquitaine cohort, 2002-2003. Clin Infect Dis 2005;40:750-753.
5. Lok AS, Lai CL, Wu PC: Prevalence of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection: implications in hepatitis B vaccination programs. Hepatology 1988;8:766-770.
6. Gandhi RT, Wurcel A, Lee H, McGovern B, Boczanowski M, Gerwin R, Corcoran CP, Szczepiorkowski Z, Toner S, Cohen DE, Sax PE, Ukomadu C: Isolated antibody to hepatitis B core antigen in human immunodeficiency virus type-1infected individuals. Clin Infect Dis 2003;36:1602-1605.
7. Brechot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Brechot P: Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely 'occult'? Hepatology 2001;34:194-203.
8. Conjeevaram HS, Lok AS: Occult hepatitis B virus infection: a hidden menace? Hepatology 2001;34:204-206.
9. Allain JP: Occult hepatitis B virus infection: implications in transfusion. Vox Sang 2004;86:83-91.
10. Thio CL: Management of chronic hepatitis B in the HIV-infected patient. AIDS Read 2004;14:122-129, 133, 136-137.
11. Sucupira MV, Mello FC, Santos EA, Niel C, Rolla VC, Arabe J, Gomes SA: Patterns of hepatitis B virus infection in Brazilian human immunodeficiency virus infected patients: high prevalence of occult infection and low frequency of lamivudine resistant mutations. Mem Inst Oswaldo Cruz 2006;101:655-660.
12. Alavian SM, Fallahian F, Lankarani KB: The changing epidemiology of viral hepatitis B in Iran. J Gastrointestin Liver Dis 2007;16:403-406.
13. Merat S, Malekzadeh R, Rezvan H, Khatibian M: Hepatitis B in Iran. Arch Iran Med 2000;3:192-201.
14. Honarkar Z, Alavian SM, Samiee S, Saeedfar K, Zali MR: Occult hepatitis B among chronic liver disease patients. Saudi Med J 2005;26:601-606.
15. Kaviani MJ, Behbahani B, Mosallaii MJ, Sari-Aslani F, Taghavi SA: Occult hepatitis B virus infection and cryptogenic chronic hepatitis in an area with intermediate prevalence of HBV infection. World J Gastroenterol 2006;12:5048-5050.
16. Carman WF: The clinical significance of surface antigen variants of hepatitis B virus. J Viral Hepat 1997;4(suppl 1):11-20.
17. Zuckerman AJ: Effect of hepatitis B virus mutants on efficacy of vaccination. Lancet 2000;355:1382-1384.
18. Liang TJ, Blum HE, Wands JR: Characterization and biological properties of a hepatitis B virus isolated from a patient without hepatitis B virus serologic markers. Hepatology 1990;12:204-212.
19. Ackerman Z, Wands JR, Gazitt Y, Brechot C, Kew MC, Shouval D: Enhancement of HBsAg detection in serum of patients with chronic liver disease following removal of circulating immune complexes. J Hepatol 1994;20:398-404.
20. Hu KQ: Occult hepatitis B virus infection and its clinical implications. J Viral Hepat 2002;9:243-257.
21. Mphahlele MJ, Lukhwareni A, Burnett RJ, Moropeng LM, Ngobeni JM: High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa. J Clin Virol 2006;35:14-20.
22. Nunez M, Rios P, Perez-Olmeda M, Soriano V: Lack of 'occult' hepatitis B virus infection in HIV-infected patients. AIDS 2002;16:2099-2101.
23. Shire NJ, Rouster SD, Rajicic N, Sherman KE: Occult hepatitis B in HIV-infected patients. J Acquir Immune Defic Syndr 2004;36:869-875.
24. Hofer M, Joller-Jemelka HI, Grob PJ, Luthy R, Opravil M: Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. Swiss HIV Cohort Study. Eur J Clin Microbiol Infect Dis 1998;17:6-13.
25. Piroth L, Binquet C, Vergne M, Minello A, Livry C, Bour JB, Buisson M, Duong M, Grappin M, Portier H, Chavanet P: The evolution of hepatitis B virus serological patterns and the clinical relevance of isolated antibodies to hepatitis B core antigen in HIV infected patients. J Hepatol 2002;36:681-686.
26. Santos EA, Yoshida CF, Rolla VC, Mendes JM, Vieira IF, Arabe J, Gomes SA: Frequent occult hepatitis B virus infection in patients infected with human immunodeficiency virus type 1. Eur J Clin Microbiol Infect Dis 2003;22:92-98.
27. Filippini P, Coppola N, Pisapia R, Scolastico C, Marrocco C, Zaccariello A, Nacca C, Sagnelli C, De Stefano G, Ferraro T, De Stefano C, Sagnelli E: Impact of occult hepatitis B virus infection in HIV patients naive for antiretroviral therapy. AIDS 2006;20:1253-1260.
28. Nebbia G, Garcia-Diaz A, Ayliffe U, Smith C, Dervisevic S, Johnson M, Gilson R, Tedder R, Geretti AM: Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons. J Med Virol 2007;79:1464-1471.
29. Fujiwara K, Tanaka Y, Orito E, Ohno T, Kato T, Sugauchi F, et al: Lack of association between occult hepatitis B virus DNA viral load and aminotransferase levels in patients with hepatitis C virus-related chronic liver disease. J Gastroenterol Hepatol 2004;19:1343-1347.